Neuroprotective effect of combination therapy of glatiramer acetate and epigallocatechin-3-gallate in neuroinflammation.
Multiple sclerosis (MS) is an inflammatory autoimmune disease of the central nervous system. However, studies of MS and the animal model, experimental autoimmune encephalomyelitis (EAE), indicate that neuronal pathology is the principle cause of clinical disability. Thus, there is need to develop ne...
Main Authors: | Katja Herges, Jason M Millward, Nicole Hentschel, Carmen Infante-Duarte, Orhan Aktas, Frauke Zipp |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2011-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3192751?pdf=render |
Similar Items
-
Treatment of Chronic Experimental Autoimmune Encephalomyelitis with Epigallocatechin-3-Gallate and Glatiramer Acetate Alters Expression of Heme-Oxygenase-1.
by: Antonia Janssen, et al.
Published: (2015-01-01) -
Epigallocatechin-3-Gallate (EGCG): New Therapeutic Perspectives for Neuroprotection, Aging, and Neuroinflammation for the Modern Age
by: Ashley Payne, et al.
Published: (2022-02-01) -
Glatiramer Acetate Immunomodulation: Evidence of Neuroprotection and Cognitive Preservation
by: Arielle Kasindi, et al.
Published: (2022-05-01) -
Effect of α-Glucosylation on the Stability, Antioxidant Properties, Toxicity, and Neuroprotective Activity of (–)-Epigallocatechin Gallate
by: Jose L. Gonzalez-Alfonso, et al.
Published: (2019-03-01) -
Epigallocatechin gallate: a review
by: L. Bartosikova, et al.
Published: (2018-10-01)